Ozempic era is just a beginning

Just one year ago, since the noise was about the drugs of the Ozamic and Wougevi, talking about its “ending obesity” capabilities by helping people to drop large amounts of weight.

Then there was a talk about how the gravity of the semules of weight loss caused a shortage of people who need to treat diabetes, as well as celebrities who may be at their hands. Despite the duct, these treatments were somewhat strange.

Today, there is no longer talking about the deficiency. In fact, it is easier than ever obtaining these drugs from pharmacies online, provided that you have the money and the appropriate body mass index. At lightning speed, strikes have become home names. You or anyone you know may take one.

Some data indicate that up to 1 in 8 people in the United States have tried one of the new drugs of weight loss drugs; In Britain, about 1 out of 7 people took one person or have a family member or a friend of his action. It is fair to say that we live in the OzemPic era, and it changes much more than our collective waist lines.

In this special report, we take a clear look at the new natural and the questions it raises. What do these treatments mean for the traditional approach to losing weight, especially the exercise (see “Why is the exercise more important than ever when taking the drugs that lose weight”), and will people who receive drugs really need to continue to take them for life (see “GLP-1 drugs are only the beginning-the strong drugs you expect”)? Over the past year, we saw the study after studying its benefits for other cases, including Alzheimer’s, depression and addiction. How do they affect the brain beyond the regulation of appetite (see “What does GLP-1 drugs really tell us about the bonus system in the brain?”)?

Many people try to take them in smaller doses, but is this a good idea (see “Microding GLP-1 drugs in a height-but do you work?”)? We also ask what all this means to society as a whole (see “the unexpected effects of society that is transformed by weight loss medications”) and what comes after that (see “the GLP-1 medications is only the beginning-strong drugs that can be expected after that”).

What is clear is that the new boom in weight loss medications is just a start. In another year, things are likely to look completely different again.